COMMUNIQUÉS West-GlobeNewswire

Dynavax Technologies Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
01/03/2018
BERKELEY, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX ) today announced that on March 1, 2018 the Compensation Committee of Dynavax’s Board of Directors approved the grant [...]
MyoKardia to Report Fourth Quarter and Full Year 2017 Financial Results on Thursday, March 8, 2018
01/03/2018
SOUTH SAN FRANCISCO, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK ), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]
Zafgen to Host Conference Call to Discuss Fourth Quarter and Full Year 2017 Financial Results
01/03/2018
BOSTON, March 01, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq: ZFGN ), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients [...]
Beleave Provides Update on Manitoba Retail Licensing Agreement
01/03/2018
TORONTO, March 01, 2018 (GLOBE NEWSWIRE) -- Beleave Inc. (" Beleave " or the " Company ") (CSE:BE); (OTCQX:BLEVF) would like to provide an update with regard to recent retail licensing grants in the province of Manitoba [...]
Teladoc Announces Expanded Collaboration with Microsoft
01/03/2018
PURCHASE, NY, March 01, 2018 (GLOBE NEWSWIRE) -- Teladoc , Inc. (NYSE: TDOC ), the world’s largest and most trusted provider of virtual care delivery services, announced today its expanded collaboration with Microsoft. [...]
Ovid Therapeutics Announces Multiple Poster Presentations of OV101 and TAK-935/OV935 at the American Academy of Neurology 70th Annual Meeting
01/03/2018
NEW YORK, March 01, 2018 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID ), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, [...]
Ritter Pharmaceuticals, Inc.’s Board Approves 1-for-10 Reverse Stock Split
01/03/2018
Los Angeles, California, March 01, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a leading developer of novel therapeutic products that modulate the [...]
TESARO Announces Participation at Two Investor Conferences
01/03/2018
WALTHAM, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO ), an oncology-focused biopharmaceutical company, today announced its participation in two upcoming investor conferences. The two conferences [...]
Humanigen CEO to Present at Inaugural LD Micro Virtual Conference
01/03/2018
BRISBANE, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company pursuing cutting-edge science to develop its proprietary monoclonal antibodies for immunotherapy and [...]
Corvus Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update
01/03/2018
BURLINGAME, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS ), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]
Genesis HealthCare Regains Compliance With NYSE Continued Listing Standard
01/03/2018
KENNETT SQUARE, Pa., March 01, 2018 (GLOBE NEWSWIRE) -- Genesis HealthCare (NYSE: GEN ) (Genesis or the Company), one of the nation’s largest providers of post-acute care, today announced that it received written [...]
CytomX to Present at Upcoming Investor Conferences
01/03/2018
SOUTH SAN FRANCISCO, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX ), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today [...]
ICU Medical, Inc. Announces Fourth Quarter and Fiscal Year 2017 Results
01/03/2018
SAN CLEMENTE, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI ), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care [...]
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
01/03/2018
BOSTON, March 01, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK ), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]
Diversicare Announces 2017 Fourth Quarter Results
01/03/2018
BRENTWOOD, Tenn., March 01, 2018 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR ), a premier provider of long-term care services, today announced its results for the fourth quarter ended [...]
OPKO Health Reports 2017 Fourth Quarter Business Highlights and Financial Results
01/03/2018
MIAMI, March 01, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK ) reports business highlights and financial results for the three months ended December 31, 2017. Business Highlights RAYALDEE total prescriptions [...]
Cidara Announces Appointment of Chrysa Mineo as Independent Director
01/03/2018
SAN DIEGO, March 01, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX ), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the appointment of Chrysa [...]
Quotient Limited to Participate in the Cowen 38th Annual Global Health Care Conference
01/03/2018
JERSEY, Channel Islands, March 01, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT ), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Paul Cowan, [...]
Versartis Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
01/03/2018
MENLO PARK, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Versartis, Inc . (NASDAQ: VSAR ), an endocrine-focused biopharmaceutical company, today announced financial results for the fourth quarter and full year ended [...]

Pages